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Gangliosides, found in blood, tissues and in human breast milk, are sialic acid-containing glyco-
sphingolipids with implicated bioactivities in neural and brain development, maturation of the gastro-
intestinal tract, and the immune system. In a cross-sectional study, high performance liquid
chromatography-mass spectrometry was used to measure the average total ganglioside concentrations
in Malaysian mothers' colostrum and transitional milk; results were 26.8 and 18.9 mg L1, respectively. In
mature milk, the average ganglioside concentrations at 2, 6, and 12 months lactation were 14.8, 25.3, and
16.6 mg L1, respectively. Considering the data from the typical exclusive breast feeding period (2 and 6
months) and adjusting for outliers, the trimmed mean was 18.5 mg L1. The average total ganglioside
concentrations in maternal serum increased from 14.7 mg L1 during the second trimester to 19.6 mg L1
during the third trimester. However, in 45% of the mothers total serum ganglioside decreased in the third
trimester.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Gangliosides (GAs) belong to the sphingolipid family and are
distinguished by a ceramide moiety attached to sialic acid-
containing complex oligosaccharides. The diversity of GAs de-
pends on the degree of glycosylation (especially sialylation) and the
variety of glycosidic linkages, giving rise to different classes of GAs.
The common classiﬁcation of GAs, devised by Svennerholm (1963),
relies on the variety of the sialo-oligosaccharide groups that are
found in GAs, but extra complexity exists due to the variety of fatty
acids (FAs) found in the ceramide. The FA (or molecular species)
proﬁle of a GA family varies with the organism and the tissue or
ﬂuid.
GAs play important roles in neurological development, memory
formation, and synaptic and transmembrane signal transduction.ong).
Ltd. This is an open access article uThey have also been implicated in regulating the immune system,
supporting intestinal maturation, protecting against enteric path-
ogens, and promoting Biﬁdobacterium proliferation in the gut of
infants. The biological roles of GAs (both endogenously synthesised
and dietary sourced) are well discussed by various researchers
(McJarrow, Schnell, Jumpsen, & Clandinin, 2009; Rueda, 2007;
Rueda & Gil, 1998; Sonnino, Mauri, Ciampa, & Prinetti, 2013).
Different GAs are found in various biological ﬂuids (blood and
milk) and in tissues (nerves, muscle, and brain). They are part of the
cell plasma membrane in blood, whereas they are part of the milk
fat globule membrane in milk (Jensen, Ferris, Lammi-Keefe, &
Henderson, 1990; McJarrow et al., 2009).
There is growing evidence that dietary GAs, such as those from
human breast milk (HBM), can have a variety of beneﬁts, which has
led to investigations into the types of GA and their concentrations
in HBM. Although there is some consistency in that the mono-
sialylated variant GM3 (a-Neu5Ac(2e3)-b-D-Galp(1e4)-b-D-
Glcp(1e1)-Cer) and the di-sialylated variant GD3 (a-Neu5Ac(2e8)-
a-Neu5Ac(2e3)-b-D-Galp(1e4)-b-D-Glcp(1e1)-Cer) are the majornder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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with the sum of GM3 and GD3 ranging from as low as 2 mg L1
(Martin-Sosa, Martin, Castro, Cabezas, & Hueso, 2004) to as high as
25 mg L1 (Pan & Izumi, 1999) when converted from lipid bound
sialic acid (LBSA). This variation could be due to sampling, extrac-
tion protocol, population demographics, diet, and analytical
methodologies (Jensen et al., 1995). Differences in protocol design
(either cross-sectional or longitudinal) and number of donors can
also add to this variability. The different GAs found in breast milk
and at different stages of lactation may be inﬂuenced by diet and
may have different roles in infant development. It is therefore
important that accurate data on HBM GA content are available.
The majority of the HBM GA concentrations have been
measured using scanned high performance thin layer chromatog-
raphy (HPTLC) plates coupled with total LBSA colorimetric assays.
Given the variety of GA masses within 1 family and the variation in
FA composition, it is difﬁcult to arrive at an accurate concentration
by this approach; in addition, HPTLC methods tend to have large
variability and low recovery (Laegreid, Otnaess,& Fuglesang, 1986).
More recently, high-performance liquid chromatography-mass
spectrometry (HPLC-MS) methods with high extraction re-
coveries, sensitivity, and speciﬁcity have been used for the quan-
tiﬁcation of GAs in bovine milk (Fong, Norris, & McJarrow, 2011;
Lee, German, Kjelden, Lebrilla, & Barile, 2013; Sorensen, 2006;
Zhang et al., 2012) and biological samples (Fong, Norris, Lowe, &
McJarrow, 2009; Garcia, Chavez, & Mechref, 2014; Huang et al.,
2014), but only 2 reported applications for the quantiﬁcation of
HBM GAs (Giuffrida, Elmelegy, Thakkar, Marmet, & Destaillats,
2014; Thakkar et al., 2013).
In this study, we report the use of a validated HPLC-MS/MS
method in multiple reaction monitoring (MRM) mode for the
quantiﬁcation of the GA concentrations in breast milk from
Malaysianmothers in a cross sectional study. There are currently no
GA data in the literature for this population group. In addition to the
cross sectional study, a longitudinal study was also under taken to
understand the changes in the GA concentrations in breast milk of
individual mothers during lactation. This information is currently
lacking in the literature. In this study, we also investigated whether
the GA concentrations in maternal serum change over the second
and third pregnancy trimesters, given that there is an increased
incorporation of GAs in the developing infant brain over this period
(Svennerholm et al., 1989).2. Materials and methods
2.1. Standards and chemicals
Ganglioside variant stock standards (GM1, bovine brain; GM2,
human brain; GM3, bovine buttermilk; GD1a, bovine brain; GD1b,
bovine brain; GD3, bovine buttermilk; GT1b, bovine brain; GQ1b,
bovine brain) were obtained from Matreya, LLC (Pleasant Gap, PA,
USA). All solvents were of liquid chromatography grade (Merck,
Darmstadt, Germany), except for chloroform, which was analytical
grade (ethanol stabilised).2.2. Study design
The samples were obtained from the Hospital Universiti Sains
Malaysia (HUSM) Pregnancy Cohort Study (Loy & Hamid, 2014),
which was conducted between April 2010 and December 2012 in
Kelantan, Malaysia. The study protocol was approved by the Human
Research Ethics Committee of USM [JEPeM 210.03 (03)] and the
Medical Research Ethics Committee of the Ministry of Health,
Malaysia (NMRR-10-597-6110).Pregnant women were recruited from the Obstetrics and Gy-
naecology Clinic of HUSM and the Kubang Kerian Health Clinic,
Kota Bharu. The inclusion criteria were deﬁned as (i) Malaysian and
Malay ethnicity, (ii) aged 19e40 years, (iii) singleton pregnancy, (iv)
gestational age  24 weeks based on the last menstrual period or
early ultrasound examination, (v) plan to give birth in HUSM, and
(vi) live within a distance of 50 km from HUSM. Exclusion criteria
included (i) diagnosed with pre-existing chronic diseases or preg-
nancy complications and (ii) preterm delivery before 37 weeks of
gestation. These recruited mothers provided blood samples during
the second trimester (14e24 gestational weeks) and third trimester
of pregnancy (32 gestational weeks). Post birth, colostrum (milk
from day 1e5 postpartum), transitional milk (milk from day 6e15
postpartum) and (mature milk after 15 days postpartum at 2, 6 and
12 month) samples were collected during clinic visits.2.3. Human breast milk samples
HBM samples were collected as a full breast expression, using an
electric breast pump from 1 breast during clinic visits. Every effort
was made to collect fore, mid and hind milk during each collection.
After mixing, a subsample of milk was taken and frozen at 80 C.
The remaining milk was returned to the mothers.
A cross sectional sample set contained a total of 48mothers who
providedmature HBM samples at the 2, 6 and 12month time points
of which a subset of 26 provided samples at all three time points
(longitudinal study). However, only 24 and 12mothers were able to
provide colostrum and transitional milk samples, respectively, of
whom 19 and 5, respectively, were in the longitudinal subset. The
statistical power of the study was not determined for the calcula-
tion of sample size as this was considered as an observational study.
All samples were individual samples except for GA sphingosine
molecular species proﬁling where ten randomly chosen HBM from
different mothers across the 3 times points (4 from 2months, and 3
from 6 to 12 months respectively) were subsampled (1 mL each)
and pooled together.2.4. Maternal blood
Fasting blood samples were drawn from the pregnant mothers
during the second and third trimesters. Serum samples were pre-
pared and frozen at 80 C prior to analysis. A total of 23 mothers
provided blood samples for both trimesters.2.5. Macronutrient analysis
The fat, protein, and lactose concentrations in the mature breast
milk samples were determined using a HumanMilk Analyzer (Miris
AB, Uppsala, Sweden). The instrument was calibrated prior to
sample analysis according to the manufacturer's instructions. The
frozen breast milk samples were warmed to 40 C in a water bath,
sonicated for 1 min, and then loaded into the instrument. The re-
sults were fat, true protein, and lactose concentrations as well as
the energy content (not used in this study).2.6. Lipid extraction for high performance liquid chromatography-
mass spectrometry analysis
Lipids from the HBM (0.25 mL) and maternal serum
(0.1e0.2 mL) samples were extracted using the modiﬁed
Svennerholm and Fredman (1980) extraction protocol as described
by Fong et al. (2009) The ﬁnal polar methanol/water fraction con-
taining the GAs was diluted and used for GA analysis.
L. Ma et al. / International Dairy Journal 49 (2015) 62e71642.7. High performance liquid chromatography-mass spectrometry
quantiﬁcation of gangliosides
HPLC separation of GAswas performed on an Agilent 1100 series
HPLC system (Santa Clara, CA, USA) equipped with an APS-2
Hypersil column (150 mm  2.1 mm, 3 mm, Thermo Electron Cor-
poration, Waltham, MA, USA), as described by Fong et al. (2009).
Eluate from the HPLC systemwas introduced into an SCIEX 6500
QTRAP mass spectrometer using an electrospray ionisation (ESI)
probe inlet. Ions were generated and focused using an ESI voltage
of 4500 V, a curtain gas of 20 L min1, and a temperature of
600 C, and GS1 and GS2 were set to 85 and 50, respectively. The Q1
and Q3 scanwidths were set at 0.2 and 0.7 scan, respectively, with a
scan range from 700 to 1650 m/z.
The mass spectrometer was optimised to measure 8 different
classes of GA (GM1, GM2, GM3, GD3, GD1a, GD1b, GT1b, and GQ1b)
using MRM in negative ion mode. Due to the absence of N-glyco-
lylneuraminic acid in human tissue and serum (Yu & Ledeen, 1972)
only GAs containing the sialic acid N-acetylneuraminic acid, were
measured. The GA concentration for each class was determined by
summing the intensities of their respective molecular species to
give a single total intensity peak.
The distribution of the individual GA molecular species for the
single pooled HBM sample (n ¼ 10) was measured using a high
resolution Thermo LTQ- OrbiTrap™ mass spectrometer (Thermo
Electron Corporation), as described by Fong et al. (2009). Elute from
the same HPLC setup was introduced into the LTQ-Thermo Orbi-
trap™ mass spectrometer via ESI probe inlet at 4500 V, a sheath
gas of 30, auxiliary gas ﬂow of 10, and capillary temperature of
300 C. MS data acquisition was carried out in negative ion mode
with a resolution of 30,000 over 700e1650 m/z.
2.8. Standard preparation
Individual GA stock standards were prepared at 1.0 or
0.5 mg mL1 in methanol (50%). An intermediate mixed standard
solution was prepared from each stock solution into a 5 mL volu-
metric ﬂask, and was serially diluted further in methanol (50%) to
give a 10-point calibration curve from 0.005 to 2.5 mg mL1. All
solutions were stored at 30 C.
2.9. Accuracy and repeatability
The accuracy of themethod andmatrix suppression effects were
evaluated using spike recovery studies and standard addition,
whereas the repeatability of the method was determined by
repeated analysis of several quality samples in each batch of anal-
ysis carried out on different days over the course of this study using
2 different operators, using the guidelines from Taylor (1987). The
repeatability coefﬁcient of variationwas determined as the percent
of the standard deviation divided by the mean.
In the standard addition protocol, two HBM samples were
chosen, one with low GA concentration (from 2 months lactation),
and other with high GA concentration (from 6 months) for spiking.
The aim was to bracket the GA concentration range typically re-
ported in HBM for ourmatrix effect study. The 2 samples came from
different donors. The samples were spiked with increasing con-
centrations of GA standard solution (0.3, 0.6, and 1.2 mg mL1).
2.10. Statistical analysis
All statistical analyses were conducted using Minitab (Release
16.2.4, 2013, Minitab Inc., State College, PA). Comparison of GA re-
sults across different time points was conducted using the gener-
alised linear model, while comparison between 2 groups of datawas conducted using paired t-test. Regression analysis was used to
determine relationship between total GA and fat.
3. Results
3.1. Methodology
In this study, we used the HPLC-MS protocol as described by
Fong et al. (2009), but employed an SCIEX 6500 QTRAP mass
spectrometer under MRM in negative ion mode to detect and
measure GAs in the maternal serum and breast milk samples. The
major molecular species for each class of GA identiﬁed from the
mass spectra (Fig. 1) of the calibration standards, HBM, and serum
were quantiﬁed using the most intense commonm/z 290 fragment
ion (sialic acid). The second most intense fragment ion was used as
a qualiﬁer ion (Table 1). We also included extra molecular species
from the identiﬁcation, GD3 m/z 775.9 and m/z 734.9 and GM3 m/z
1179.7 and m/z 1261.8, which are found in relatively higher
amounts in HBM and serum than in bovine milk.
3.2. Method validation
The ESI process in MS is prone to matrix effects, typically sup-
pression of ionisation. This was evaluated by comparing the stan-
dard addition results with the results obtained using the described
HPLC-MS method calibrated against external standards. The stan-
dard addition results were not signiﬁcantly different from the
external standard method results (Table 2), indicating the absence
of any major matrix effects.
We also evaluated the accuracy of the HPLC-MS method using
spike recovery experiments for both the HBM samples and the
maternal serum samples. Samples were spiked with approximately
twice the endogenous level of GAs. Near 100% recovery was
measured for GD3 and GM3 in the breast milk samples, whereas
95e105% recovery was observed for the maternal serum samples
(Table 2). These recoveries are consistent with those (96e103%)
that we reported previously for dairy products (Fong et al., 2011)
using the same extraction protocol, giving us conﬁdence that the
extraction protocol was robust.
The repeatability of the method, determined as the percentage
CV, was 5.3e8.0% for HBM GAs while for maternal serum GAs, the
CV was 0.7e11.8%. Higher percentage CVs in the serum samples
were typical observed for the lower serum GM2, GD1a, and GD1b GA
concentrations (Table 2). The limit of detection (LOD) was deter-
mined by loading decreasing amounts of GA standards on to the
HPLC-MS system to give a signal that was approximately 3e4 times
the noise level. The limit of quantitation (LOQ) was determined as
approximately 10 times the noise level (Table 2).
3.3. Macronutrient composition
The Human Milk Analyzer used for macronutrient analysis has
been reported to have a small bias in its measurement (Casadio
et al., 2010). We did not consider this to be signiﬁcant for this
study, and have reported the results as determined with the
instrument.
Overall, we observed a large inter-individual variation in the
macronutrient concentration in the mature milk samples within
each lactation time point (2, 6, and 12 months; Fig. 2) in this study.
However, the averaged concentrations weremore consistent at 9, 7,
and 9 g L1 for protein and 65, 67, and 67 g L1 for lactose at 2, 6,
and 12 months, respectively. In contrast, the average fat concen-
tration increased across these 3 lactation time points, from 32 to 38
and to 40 g L1, respectively (Fig. 2). The macronutrients in the
Fig. 1. The mass spectra of gangliosides GM3 and GD3 observed in Malaysian mothers' breast milk (A, D), Malaysian mothers' serum (B, E), and bovine-sourced calibration standards
(C, F) acquired on the high resolution OrbiTrap™mass spectrometer. Only the major (and some minor) molecular species were tentatively identiﬁed by d-value (the sum of carbon
atoms and the number of double bonds attached to the dihydroxysphingosine base and their fatty acid moieties).
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limited sample volumes.
3.4. Gangliosides in breast milk
The cross-sectional study showed that the average total GA
concentration was highest in the colostrum samples
(26.8 mg L1), decreasing to 18.9 mg L1 in the transitional milk
and to 14.8 mg L1 in the 2-month mature milk, respectively.
This was followed by an increase at 6 month to 22.5 mg L1,
before the concentration fell again to 16.2 mg L1 by 12 month
(Table 3). We also observed a large spread in the GAconcentrations within each lactation time point (Fig. 2),
reﬂecting large inter-individual variation. Typically, the level of
GA was related to fat concentration and a signiﬁcant correlation
was found (Fig. 3).
From the data, changes in the GD3:GM3 ratio through the
lactation period were seenwith the relative amount of GD3, highest
in colostrum, with a GD3:GM3 ratio of 3:1, and decreasing ratio of
1.3:1 for the transitional and 0.8:1 for 2-month mature milk sam-
ples. The GD3:GM3 ratio appeared to stabilise at 0.17:1 for the 6e12-
month lactation samples and GM3 was the dominant GA class
(86e89% of the total GAs measured, n ¼ 84) during this 6e12-
month lactation period (Fig. 2).
Table 1
Ganglioside (GA) molecular species and daughter fragments, and mass spectrometry conditions used for GA quantiﬁcation.a
Ganglioside class
[molecular ion charge]




Collision energy Collision exit potential
GM1 [MeH]‒ 1544.9 d36:1 290.1 888.5 275 75 10
1572.9 d38:1 290.1 916.7
GM2 [MeH]e 1410.7 d38:1 290.1 1119.8 20 65 10
1382.8 d36:1 290.1 1091.7
GM3 [MeH]e 1151.7 d34:1 290.1 860.5 40 65 15
1179.8 d36:1 290.1 888.8
1207.8 d38:1 290.1 916.2
1221.8 d39:1 290.1 606.6
1235.8 d40:1 290.1 944.7
1249.8 d41:1 290.1 958.6
1261.8 d42:2 290.1 970.6
1263.8 d42:1 290.1 972.6
1279.8 d43:0 290.1 986.7
GD3 [Me2H]2e 720.9 d34:1 290.1 581.1 20 40 10
734.9 d36:1 290.1 581.1
748.9 d38:1 290.1 581.1
755.9 d39:1 290.1 581.1
762.9 d40:1 290.1 581.1
769.9 d41:1 290.1 581.1
775.9 d42:2 290.1 581.1
776.0 d42:1 290.1 581.1
784.9 d43:0 290.1 581.1
GD1a/b [Me2H]2e 917.5 d36:1 290.1 888.6 20 45 10
931.5 d38:1 290.1 581.1
GT1b [Me2H]2e 1063.0 d36:1 290.1 917.6 20 35 10
1077.0 d38:1 290.1 931.5
GQ1b [Me3H]3e 805.4 d36:1 290.1 581.1 20 55 10
814.7 d38:1 290.1 814.7
GQ1b [Me2H]2e 1208.6 d36:1 290.1 581.1
1222.6 d38:1 290.1 581.1
a GD3 and GD1a/b, and GT1b were present predominantly as [MeH]2. As GQ1b molecular ions [Me2H]2 and [Me3H]3were present in similar proportions, both were used
for quantiﬁcation. d-Value refers to the sum of carbon atoms and the number of double bonds attached to the dihydroxysphingosine base and their fatty acid moieties.
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and proportion in of the milk from individual mothers was
observed over the lactation period. The average GA concentrations
from this longitudinal study were very similar to the larger cross-
sectional study (Table 3).
As well as inter-individual differences, intra-individual variation
in the GA concentrations was observed (Table 3) in the colostrum,
transitional milk, and mature milk samples. For example, although,
on average, the colostrum GA concentrations were highest through
the lactation period, at an individual level, some mothers showed
less GA in their colostrum than in their mature milk. Likewise, for
mature milk, mothers who may have started off with high GATable 2
Method validation [standard addition, recovery, repeatability, limit of detection (LOD),
samples.a
Samples GM3 GD3
Breast milk 1 External standard (n ¼ 4) 7.9 ± 0.3a 4.8 ± 0.3
Standard addition (n ¼ 4) 7.7 ± 0.03a 4.6 ± 0.2
Breast milk 2 External standard (n ¼ 2) 27.6 ± 1.2c 5.8 ± 0.6
Standard addition (n ¼ 2) 28.0 ± 1.5c 5.4 ± 0.1
Breast milk 3 Repeatability (n ¼ 17) 34.3 ± 2.4 (7.2%) 5.1 ± 0.4
Breast milk 4 Repeatability (n ¼ 7) 7.7 ± 0.5 (6.7%) 4.4 ± 0.3
Breast milk 5 Repeatability (n ¼ 7) 3.3 ± 0.2 (6%) 0.4 ± 0.0
Breast milk 6 Repeatability (n ¼ 6) 0.9 ± 0.07 (8%) 11.2 ± 0.
Breast milk 7 Percent recovery (n ¼ 4) 99 ± 4 (4%) 101 ± 5 (
Serum 1 External (n ¼ 2) 27 ± 0e 0.8 ± 0f
Standard addition (n ¼ 2) 28 ± 6e 1.0 ± 0.2
Serum 2 Repeatability (n ¼ 4) 32.6 ± 1.92 (5.9%) 1.3 ± 0.0
Serum 3 Repeatability (n ¼ 6) 9.7 ± 0.57 (5.9%) 0.6 ± 0.0
Serum 4 Percent recovery (n ¼ 6) 101 ± 6 (6%) 97 ± 5 (5
LOD ng loaded on column 0.02 0.02
LOQ ng loaded on column 0.02 0.05
a The percentage CVs for serum and breast milk are provided in parentheses; units a
determined for HBM. Superscript letters denote paired t-test between the external stanconcentrations at 2 months did not necessarily maintain that level
through the 6- and 12-month time points, or vice versa. In addition,
some mothers displayed less dramatic changes in GAs over the 3
time points. Overall, there were many variations in the HBM GA
concentrations throughout lactation, both on an individual mother
basis and between mothers.3.5. Ganglioside molecular species in human breast milk
The GA molecular species from the pooled HBM (n ¼ 10) in our
study were tentatively identiﬁed by d-value (the sum of carbon











0.4 ± 0g 0.4 ± 0.04h 0.4 ± 0.04i
f 0.6 ± 0.2g 0.4 ± 0.04h 0.5 ± 0.1i
3 (2.1%) 0.2 ± 0.02 (10.5%) 0.4 ± 0.002 (0.7%) 0.1 ± 0.02 (11.2%)
5 (8.3%) 0.1 ± 0.01 (7.9%) 0.2 ± 0.02 (9.0%) 0.1 ± 0.01 (11.8%)
%) 97 ± 8 (9%) 102 ± 6 (6%) 101 ± 3 (3%)
0.02 0.02 0.02
0.02 0.05 0.05
re mg L1 ± standard deviation. The percent recoveries of only GD3 and GM3 were
dard and standard addition results were not signiﬁcantly different (p > 0.05).
Fig. 2. The fat (A), protein (B), carbohydrate (C), total ganglioside (D), GM3 (E), and GD3 (F) concentrations in Malaysian breast milk samples across the 12-month cross-sectional
study. The maternal ganglioside concentrations for the second trimester (2TM) and the third trimester (3TM) from the same cross-sectional study are presented in G, H, and I. The
95% conﬁdence level is provided, with the mean values for each time point linked by a connecting line.
L. Ma et al. / International Dairy Journal 49 (2015) 62e71 67base) and FA composition (with d18:1 being the assumed major
sphingosine FA, followed by the acylated FA) based on the accurate
mass data, the MS/MS data, and the FA composition published by
Bode, Beermann, Mank, Kohn, and Boehm (2004).
The most abundant GM3 molecular species observed for the
pooled Malaysian milk sample was m/z 1261.8 (d42:2, d18:1/24:1),
with the least abundant GM3 molecular species being m/z 1179.7
(d36:1, d18:1/18:0; Fig 1). We also observed trace levels of medium
chain FAs containing the GM3 molecular species m/z 1123.6 (d32:1,Table 3
The ganglioside (GA) concentration of the human breast milk (HBM) and maternal serum
Milk Study Sample size GM3
Colostrum Cross-sectional 24 6.5 ± 7.0b
Longitudinal 19 7.1 ± 7.7
Transitional milk Cross-sectional 12 8.3 ± 4.8b,c
Longitudinal 5 9.6 ± 5.7
2-month mature milk Cross-sectional 48 8.3 ± 5.5c
Longitudinal 26 8.3 ± 5.5
6-month mature milk Cross-sectional 42 21.4 ± 13a
Longitudinal 26 20.4 ± 12.2
12-month mature milk Cross-sectional 42 13.8 ± 6.5b
Longitudinal 26 13.5 ± 6.7
Maternal serum (second trimester) Longitudinal 23 13.1 ± 5.4
Maternal serum (third trimester) Longitudinal 23 18.4 ± 9.2**
a The mean (mg L1) ± standard deviation for both the cross-sectional sample set and
data from the longitudinal data set for breast milk. The GA concentration is also present a
share the same superscript letter, they are not signiﬁcantly different at the 5% level of sig
and third trimester values. The asterisk(s) indicate the trimester means are signiﬁcantly
level): * signiﬁcant at the 5% level of signiﬁcance (0.01 < p < 0.05); ** signiﬁcant at the 1d18:1/14:0), which have not previously been reported in the liter-
ature, in the Malaysian HBM and bovine standards (Fig. 1).
For the GD3 GAs, the most abundant molecular species in the
pooled Malaysian HBM, in near equal intensities, were the m/z
775.7 (d42:2, d18:1/24:1) and m/z 776.9 (d42:1, d18:1/24:0) mo-
lecular ions. The m/z 720.9 (d34:1, d18:1/16:0), m/z 728.9 (d35:0,
d18:0/17:0), and m/z 734.9 (d36:1, d18:1/18:0) molecular ions, also
present in almost similar intensities, were in least abundance
(Fig. 1).samples across the different collection time points.a
GD3 GM2 GD1a GD1b Total GAs
20.3 ± 13.0a 26.8 ± 16.4a
20.2 ± 13.0 27.3 ± 16.7
10.6 ± 4.3b 18.9 ± 6.6a,b
10.3 ± 3.7 19.9 ± 8.9
6.5 ± 5.1b,c 14.8 ± 8.0 (0.5)b
6.2 ± 4.2 14.5 ± 7.6 (0.5)
4.3 ± 5.5c 25.3 ± 15.7 (0.8)a
2.7 ± 3.0 22.5 ± 14.6 (0.7)
2.8 ± 4.5c 16.6 ± 8.5 (0.5)b
2.7 ± 4.6 16.2 ± 9.0 (0.5)
0.6 ± 0.2 0.6 ± 0.8* 0.24 ± 0.2** 0.3 ± 0.3* 14.7 ± 6.2
0.7 ± 0.3** 0.2 ± 0.2 0.16 ± 0.1 0.1 ± 0.1 19.6 ± 9.4*
the longitudinal sample set are presented. The cross-sectional data set also includes
s mg g1 fat in parentheses for mature milk. For colostrum and milks, if two means
niﬁcance. For maternal serum data, the comparison is vertically between the second
different from each other (asterisk is on the trimester with the higher ganglioside
% level of signiﬁcance (0.001 < p < 0.01).
Fig. 3. A relationship plot between total ganglioside concentration and lipid concen-
tration at the 2 (▵), 6 (◊), and 12 (B) month time points from the cross-sectional
study. Signiﬁcant relationship observed with a Pearsons correlation r ¼ 0.60 and
p < 0.001.
L. Ma et al. / International Dairy Journal 49 (2015) 62e7168The molecular species distributions for the colostrum and
transitional milk samples were the same as for the mature milk
samples for the Malaysian mothers.
3.6. Maternal serum gangliosides
On average, higher total GA concentrations were measured in
the third trimester serum (19.6 mg L1) compared with the second
trimester (14.7 mg L1; Table 3). Similar to the GA variations
observed with the HBM samples, we also observed both inter-
individual variation (Fig. 2) and intra-individual variation
(Table 3) in the maternal serum GA concentrations across both
trimesters.
The predominant GA class found in the maternal serum was
GM3, with averages of 89 and 94% of the total measured GAs in the
second and third trimester serum samples, respectively. The other
minor serum GAs that were detected and measured in this study
were GD3 at 4 and 3.6%, GM2 at 4 and 1%, GD1a at 1.3 and 1%, and
GD1b at 2 and 0.5% for the second and third trimesters, respectively.
Analysis of the mass spectra (Fig. 1) showed that the maternal
serum GM3 and GD3 molecular species distribution was different
from that found in the HBM samples. Serum GM3 and GD3 had
greatest abundance of the m/z 1151 (d34:1, d18:1/16:0) and m/z
720.9 (d34:1, d18:1/16:0) molecular species, respectively, which
were in lower abundance in the HBM samples. The very long chain
FAs containing GM3 (m/z 1261.8, d42:2, d18:1/24:1) and GD3 (m/z
1263.8, d42:1, d18:1/24:0) molecular species were present at lower
abundance compared with HBM (Fig. 1).
4. Discussion
To our knowledge, this is the ﬁrst study that reports the GA and
macronutrient concentration in the HBM and the maternal serum
during pregnancy from a Malaysian population.
This study's ﬁndings on macronutrient concentrations in the
Malaysian HBM samples align with those previously reported for
other populations. The average fat concentration in the Malaysian
HBM samples increased from 32 to 40 g L1 across 12 months of
lactation and was similar to the trend reported by Jensen et al.
(1995) (from 35 to 45 g L1) and Michaelsen, Skafte, Badsberg,
and Jorgensen (1990) (from 37.3 to 48.0 g L1). The protein con-
centration in the Malaysian HBM samples also showed similar
variation (Fig. 2), but the average protein concentrations(7e9 g L1) were well within the ranges (7e15.8 g L1) reported in
the literature (Lonnerdal& Atkinson, 1995; Michaelsen et al., 1990).
The average lactose concentration in the Malaysian HBM samples
was relatively constant (65e67 g L1) through lactation but, as with
the other macronutrients, there were variations between in-
dividuals consistent with the literature (Michaelsen et al., 1990;
Newburg & Neubauer, 1995).
Malaysian HBM samples were analysed for the presence of
quantiﬁable levels of GM1a, GM2, GM3, GD1a, GD1b, GD3, GT1b, GQ1b
based on the molecular species proﬁle presented in Table 1. GT3 has
been reported previously but analysis based on accurate mass
extract (single, double and triple charge states) of the dC18:1
sphingolipid based with the common fatty acids (C16:0, C18:0,
C20:0, C21:0, C22:0, C23:0, C24:0, and C24:1) in this work was
unable to detect GT3 in any of the samples. Only two major HBM
gangliosides, GM3 and GD3, were at quantiﬁable levels in the
Malaysian HBM samples. Similarly, Lee, An, Lerno, German, and
Lebrilla (2011), using Fourier transform ion cyclotron resonance
MS, proﬁled the GA in HBM to consist of GD3 and GM3. They did not
report the presence of other GAs in their HBM sample. Giuffrida
et al. (2014) and Thakkar et al. (2013) also used an HPLC-MS
approach and only quantiﬁed GM3 and GD3. In contrast, HPTLC
methodologies were able to detect “minor” GAs in HBM (Laegreid
et al., 1986; Martin-Sosa et al., 2004; Pan & Izumi, 1999; Rueda,
Puente, Hueso, Maldonado, & Gil, 1995) in addition to the major
GD3 and GM3 GAs. These studies have inferred GT3, GM1, O-acety-
lated, branched and polysialogangliosides to be present in HBM by
their chromatographic migration times on HPTLC relative to other
known GA standards. GT3 which was estimated by HPTLC to be the
third most abundant HBM GA, making up to 9.2e45.5% of LBSA,
0.4e4 mg kg1 fresh mature milk, converted from LBSA using a GT3
averageMWof 1800 (Rueda et al., 1995), and at 22.9, 20.7 and 17.8%
total LBSA (1.0, 0.5 and 0.3 mg kg1) for colostrum, transitional milk
and mature milk respectively (Martin-Sosa et al., 2004). However,
there is currently no conﬁrmatory structural data on the identiﬁ-
cation of these “minor” GAs in HBM inferred HPTLC methods.
Confusingly, the conﬁrmation of the presence of GM1 in HBM be-
tween researchers, using HPTLC coupled to immune-staining
techniques gave contradictory results (Martin-Sosa et al., 2004;
Pan & Izumi, 2000).
GA GT3 was reported in bovine butter milk at 5.2% of total LBSA
(2.8 mg kg1 dry weight, total GA was 514 mg kg1) and conﬁrmed
by GC analysis of permethylation derivatives (Takamizawa,
Iwamori, Mutai, & Nagai, 1986a). Possibly the GT3 concentrations
were belowourMS detection limits in this study or the analysis was
for the incorrect molecular species, but GD3 and GM3 have similar
ceramide composition so, logically, GT3 should do as well as it is
synthesised from GD3, and these GT3 masses were not detected.
The total GA concentrations reported in the literature for
colostrum, transitional milk, and mature HBM show signiﬁcant
variability with a degree of this being attributable to unreported
analytical recovery efﬁciencies for multistep extractions (Laegreid
et al., 1986) (reported 50% losses), interference from non-GA in
the colorimetric assay, often very small sample size, and the use of
LBSA as the quantiﬁcation rather than speciﬁc GA. Other factors
that could impact this and previous studies results could be
whether a full breast extractionwas sampled (this study was), time
of sampling, diet (Lopez et al., 2008), ethnicity and demands of the
infant at the time (Jensen, 1995). Study protocol and sample size
could also be a contributing factor. The sample size in this study
was larger than those reported typically reported in the literature
(Table 4). Reported concentration ranges for the sum of GM3 and
GD3 are 2.8e14.3, 0.9e25.1 and 1.6e23.8 mg L1 for colostrum,
transitional milk, and mature milk, respectively, after conversion
from LBSA with assumptions derived from what percentage of the
L. Ma et al. / International Dairy Journal 49 (2015) 62e71 69LBSA is from those speciﬁc gangliosides and the average weighted
molecular weights of GM3 and GD3 (Table 4). The average total GA
(GM3 þ GD3) concentrations in the colostrum (26.8 mg L1) in our
Malaysian mothers HBM were twice that reported in the literature
for other population groups. Although our average GA concentra-
tion in the transitional milk (18.9 mg L1) and the mature milks
(14.8, 25.3 and 16.6 mg L1 for 2, 6 and 12 months, respectively)
were within the literature ranges, they were on the higher end. In
considering the data from the typical solely breast feeding period (2
and 6 months) and adjusting for outliers (trimmed top and bottom
5%), the trimmed mean is 18.5 mg L1.
All of the published quantitative HBM GA data, with the
exception of the data reported recently by Giuffrida et al. (2014) and
Thakkar et al. (2013), were determined using the traditional HPTLC
quantiﬁcation methods after a variety of generally non-validated
extraction approaches.
HPLC-MS methodology is increasingly being used for GA anal-
ysis in both biological samples and food samples (Fong et al., 2009,
2011; Garcia et al., 2014; Huang et al., 2014; Lee et al., 2013;
Sorensen, 2006; Zhang et al., 2012). Although MS has been used
for the proﬁling of GAs in HBM (Lee et al., 2011), it has only recently
been applied to the quantiﬁcation of GAs in HBM (Giuffrida et al.,
2014; Thakkar et al., 2013). The technique has greater selectivity
for GAs compared with HPTLC methods as it uses the exact GA
masses for detection and quantiﬁcation. Our HPLC-MS-MRM re-
sults were higher than those reported by Giuffrida et al. (2014) and
Thakkar et al. (2013) using an HPLC-MS method (Table 4).
Although the difference in results may be due to ethnicities of
the subjects, protocol design, and sample size, it is most likely that
some of this difference may arise from differences in the HPLC-MS
techniques employed. Our HPLC-MS method separates GA by class
and measures all the major GA molecular species observed in the
mass spectra (Fig. 1). The approach of Giuffrida et al. (2014) and
Thakkar et al. (2013) also measured similar GA molecular species
using precursor mass scan but separation occurs due to the cer-
amide composition rather than the head group sialic acid. Themass
spectrometers used by Giuffrida et al. (2014) and Thakkar et al.
(2013) (a SCIEX 5600 Triple TOF and a 5500 Triple Quad, respec-
tively) have a restricted quadruple precursor selection mass range
of m/z 5e1250 (AB SCIEX, 2001; Andrews, Simons, Young,
Hawkridge, & Muddiman, 2011), which makes it unclear how
these authors measured GM3 molecular species above the m/z
1250. We found that these species contributed approximately 30%
of the total molecular ion intensities (Fig. 1) from the Malaysian
HBM samples. This could explain the lower results for GM3 re-
ported within these papers when compared with the resultsTable 4
Summary of total ganglioside (GD3 þ GM3) concentrations reported in the literature acr
Total GA range (mg L1)
Colostrum Transitional milk Mature milk
6.4 (1e4, 12) 3.3 (12e17, 12) 1.7 (28e32, 12)
2.8e4.1 (1e5, 3) 0.9e10.7 (8e14, 6) 1.6e23.8 (11e150
10.0e15.1 (2e4, 6) 8.3e13.9 (8e14, 5) 9.3e14.4 (40e390
12e14.3 (2e5, 11) 12.5e25.1 (6e14, 35) 11.1e21.8 (21e49
10.1 (3e5, 2434 pooled)b 10e10.4 (6e15, 2434 pooled)b 10e16 (16e482, 2
11 (60e300, 10 p
4.6e5.6 (30e120,
8.1 (0e11, not provided) Combined with colostrum 9.1e10.7 (30e120
7.9e59.7 (1e5, 24) 8.4e30.7 (6e14, 12) 2.3e68.6 (60e365
a Units for ranges are mg L1; the lactation period in days and number in sample are
b Numbers of samples analysed from a pool of 2434 mothers for colostrum, transition
c Data were reported as lipid-bound sialic acid but were converted to GA using a weight
molecular species distribution observed in Fig. 1. Trisialoganglioside and polysialogangl
included in the above total GA data.obtained in this study. The weakness of HPLC-MS methods arises in
needing to know exact masses and having the proper equipment to
analyse all GA molecular species.
Inmaturemilk at each time point GA concentrationwas strongly
correlated with the fat concentration (Fig. 3). This is not unrea-
sonable as GAs are located in the milk fat globule membrane sur-
rounding the fat droplet (Lopez et al., 2008); therefore, if the GAs
were a constant proportion of the membrane composition and the
globules were a similar size, then the more fat there is, the more
membrane there will be, and hence the more GAs. This highlights
the importance of measuring the gross compositions of milk at the
same time as the minor components.
The GA lactation trend observed in our cross-sectional study
showed that the average total GA concentrationwas highest during
the colostrum period, and decreased through to mature milk, with
the exception of the 6-month average GA concentration, which was
much higher. The GA lactation trends reported in the literature are
highly variable (Table 4). However, when plotted as LBSA, the re-
ported the GA concentration is typically highest in colostrum
decreasing towards mature milk period with a possibly increase as
lactation continues (Pan & Izumi, 1999; Rueda, 2007; Rueda et al.,
1995; Takamizawa, Iwamori, Mutai, & Nagai, 1986b). The total GA
concentration in the mature milk through the lactation period
tended to show less ﬂuctuation (smaller ranges; Table 4).
The individual GD3 and GM3 lactation trends in our study re-
ﬂected the published data (Fig. 2), with GD3 being dominant in
colostrum and lowest in mature milk, and vice versa for GM3,
which is dominant in mature milk. Although the biological signif-
icance of the changes in the GD3:GM3 ratio over human lactation is
unclear, it has been postulated that a high concentration of GD3 in
early milk may reﬂect its biological role in the development of or-
gans such as the intestine (Rueda et al., 1995) and that the increase
in GM3 in mature milk is associated with signal transduction, cell
adhesion, and growth factor receptors, leading to the development
of the immune and central nervous systems (Pan & Izumi, 1999;
Rueda, 2013; Takamizawa et al., 1986b).
Following individual mothers through lactation, the longitudi-
nal study revealed, for the ﬁrst time, the large intra-individual
variability in HBM GA concentrations. This suggests that the GA
concentrations in HBM at any time point may be inﬂuence by the
mother's dietary intake of GAs, or their precursor, changing de-
mand from the feeding infant (particularly with the introduction of
food after 6 months), sample size, or may simply be inﬂuenced by
changes in fat concentration. Furthermore, we also found similar
ﬂuctuations in the fat concentrations for these individual mothers
(data not shown).oss the lactation period for breast milk.a
Ethnic group Reference
Spanish (Martin-Sosa et al., 2004)c
, 8) Spanish (Rueda et al., 1995)c
, 7) Japanese (Takamizawa et al., 1986b)c
, 10) Japanese (Pan & Izumi, 1999)c
434 pooled)b Japanese (Nakano, Sugawara, & Kawakami, 2001)
ooled) Danish (Laegreid et al., 1986)
50) Singaporean (Thakkar et al., 2013)
, not provided) Chinese (Giuffrida et al., 2014)
, 132) Malaysian This study
given in parentheses.
al milk, and mature milk were not provided.
ed averagemolecular mass of 1248 for GM3 and 1540 for GD3 calculated based of the
iosides that were tentatively identiﬁed by the HTPLC analytical methods were not
L. Ma et al. / International Dairy Journal 49 (2015) 62e7170We were able to compare the distribution of GA molecular
species obtained from our pooled Malaysian HBM samples with
only 1 other study reported in the literature using pooled HBM
fromUSmothers (ethnicity not provided; Lee et al., 2011). Themost
abundant GM3 and GD3 molecular species in the pooled US HBM
samples were those containing d18:1/22:0 FAs (GM3 m/z 1235.9,
d40:1 and GD3 m/z 762.9, d40:1). In our Malaysian HBM samples,
the most abundant molecular species were those containing the
d18:1/24:0 (d42:1) and d18:1/24:1 (d42:1) FAs that is a slightly
longer chain length.
The differences observed in the distribution of the GAmolecular
species in the 2 different populations suggest the possibility of
maternal dietary inﬂuences or genetics on GA biosynthesis. Dietary
factors inﬂuence the FA composition in HBM but have less inﬂuence
on the total fat concentration (Ballard&Morrow, 2013; Innis, 2014;
Jensen et al., 1995). The GA FA proﬁle obtained in this study sug-
gests that diet may also affect the FA composition of the GAs,
though it is noted that the serum GA FA differed from the milk GA
FA.
The GA concentration reported in infant formula (IF) is highly
variable. The typical reported GA concentrations range from 2 to
16 mg L1 (Fong et al., 2011; Pan & Izumi, 2000; Sanchez Diaz,
Ruano, Lorente, & Hueso, 1997; Sorensen, 2006), but Zhang et al.
(2012) reported two IF that had levels that were twice as high, at
21.7 and 24.5 mg L1. These variations are probably due to in-
gredients, formulations, and similarly to the HBM data analytical
methods. Only 3 studies analysed both breast milk and IF GAs
(Laegreid et al., 1986; Neeser, Golliard, & Delvedovo, 1991; Pan &
Izumi, 2000), allowing for closer comparison, the breast milk
samples had GAs at 9.3e11mg LBSA L1 whereas the infant formula
samples had GAs at 4.4e6 mg LBSA L1. Similar trends were also
reported by Sanchez-Díaz et al. (1997), although their absolute
concentration of LBSA differed: 2e5 mg L1 for HBM and
0.95e1.34 mg L1.
Some studies show higher levels of GAs in HBM compared with
IF, which suggests that perhaps the GA concentrations in IF need to
be increased and accurate data on HBM GA levels obtained to guide
the level of fortiﬁcation of IF to meet the levels found in HBM.
Furthermore, the GD3/GM3 ratio should also be considered, given
IF typically contains dairy origin GA, which is different from that in
HBM. Such IF fortiﬁcation was suggested several years ago (Rueda,
2007) due to the growing evidence of a range of biological beneﬁt
(McJarrow et al., 2009; Rueda, 2013) even though themechanism of
dietary GA uptake and incorporation is uncertain. Certainly GA
concentrations increase in the developing infant brain from in
utero through to the age of 5 (Svennerholm et al., 1989) and
increasing dietary intake has been shown in preclinical and clinical
trials to have content and functional impacts through maternal and
infant diets (Gurnida, Rowan, Idjradinata, Muchtadi, & Sekarwana,
2012; Gustavsson et al., 2010; Park et al., 2005; Vickers et al., 2009)
and the difference in the GA brain level in IF and HBM fed infants is
signiﬁcant given the lower level of GA in IF (Wang, McVeagh,
Petocz, & Brand-Miller, 2003).
Maternal serum analysis showed total GA in the range of
5.7e38 mg L1 with 89e94% of this being GM3 and 3.6e4% GD3
and lower levels of other GA (GM2, GD1a, GD1b). The average total
serum GAs increased from 14.7 mg L1 in the second trimester to
19.6 mg L1 in the third trimester. Prior to this study no data have
been available on variation of maternal serum during pregnancy.
The third trimester is a time of high GA incorporation into infant
brain (Svennerholm et al., 1989) and we hypothesise that the in-
crease in the maternal serum GA concentration over this pregnancy
period is to meet the increased GA demand of the foetus. Although
on average higher total serum GA concentrations were found in the
third trimester compared with the second trimester (Table 3), 45%of the mother showed a drop in the total serum GA from the 2nd
trimester to 3rd trimester of pregnancy. Possibly the maternal
synthesis mechanisms in these mothers were not able to match the
increased demand from the foetus.
It is unknownwhat the implication of the serum GA decrease in
some mothers over the period of high GA demand on foetal brain
development. The current data set, unfortunately, is limited. We do
not have more time point data across the 2 to 3rd trimester period
that look at changes/ﬂuctuations in the GA levels inmaternal serum
or even maternal dietary GA intake over this period of rapid
incorporation of GA into the infant brain. Placental transfer of GM3
can occur from mother to infant (Henare et al., 2009), and that
maternal supplementation of complex lipids including GA during
pregnancy has an impact on brain weight, GA and phospholipid
content in offspring in a rat model (Gustavsson et al., 2010;
Hungund, Morishima, Gokhale, & Cooper, 1993), but there is a
lack of information around the biology of GA transfer from mother
to developing infant at a time of increasing levels in the foetal brain.
How this possible GA nutritional limitation may impact on the
foetal brain development requires further research. Future studies
are also needed to investigate whether maternal serum GA status is
inﬂuenced by dietary GA intake and then the impact on the infant
GA status through placental transfer.
The distribution of GA molecular species observed in the
maternal serum samples was different from that in the HBM
samples. Themolecular species containing d18:1/16:0 (d34:1) were
the most abundant in maternal serum GA (both GM3 and GD3)
whereas the molecular species containing d18:1/24:1 (d42:2) and
d18:1/24:0 (d42:1) were the most abundant in HBM (Fig. 1). This
suggests that there are differences in the biosynthesis of GAs in
blood and in the mammary gland, and the blood GAs are more than
simply an intact transport system.5. Conclusions
In conclusion, using a modern analytical HPLC-MS technique
that is more selective and accurate than previous methods, we
found that the GA concentration in HBM samples from a cross-
section of Malaysian mothers was generally higher that those
previously reported for other population groups. In addition, this
study measured the fat and GA concentrations of the milk at the
same time, showing a concentration relationship between GAs and
fat. As HBM is the gold standard to which infant formulae are
formulated, there is awareness that numerous bioactive lipid
components are present in breast milk at signiﬁcant levels, but are
absent or in lower concentration in infant formula. These could be
added to help normal growth and development of the infant im-
mune system, visual performance, and cognitive performance.
Bioactive and essential lipid components such as arachidonic
acid and docosahexaenoic acid have already been incorporated into
infant formula and there is an argument to make that other lipid
components such as GA and phospholipids should be enriched to
HBM levels to allow optimal infant development. Similarly the
ability to measure the maternal serum GA concentrations will
enable future development of maternal and foetal prenatal
nutrition.Acknowledgements
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